Skip to main content
. 2017 Sep 25;43(12):831–840. doi: 10.1136/medethics-2016-103461

Figure 5.

Figure 5

Level of agreement to provide substitute treatments of reduced efficacy (A) and increased expense (B) when requested for varying reasons.